The CDC issued new guidelines on fully vaccinated individuals and masks. This set of public health recommendations for fully vaccinated people will be updated and expanded based on the level of community spread of SARS-CoV-2, the proportion of the population that is fully vaccinated, and the rapidly evolving science on COVID-19 vaccines.
FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following Thorough Safety Review
Following a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunization Practices, the US Food and Drug Administration and the US Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Johnson & Johnson (Janssen) COVID-19 Vaccine in the US should be lifted and use of the vaccine should resume.
On April 13, 2021, CDC and FDA recommended a pause in the use of Johnson & Johnson’s Janssen COVID-19 Vaccine.
Feelings of hope and relief filled Pepperdine’s Malibu campus on Thursday, March 11, as the SHC hosted its first COVID-19 vaccine clinic.